A β-D-N-acetylgalactosamine (GalNAcβ) ligand equipped with a terminal alkyne through a hydrophilic PEG3 spacer. The alkyne couples to azide-functionalized partners via copper-catalyzed azide-alkyne cycloaddition (CuAAC), forming stable 1,2,3-triazole linkages. This compound enables the construction of hepatocyte-targeted therapeutics and research tools that exploit the asialoglycoprotein receptor (ASGPR), which is highly expressed on liver hepatocytes and binds GalNAc-containing ligands with high affinity.